13G Filing: Partner Fund Management and Aerie Pharmaceuticals Inc (AERI)

Page 7 of 13

Page 7 of 13 – SEC Filing

CUSIP No. 00771V108 13G Page
7 of 13 Pages

1.

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Christopher M. James

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)      ¨

(b)     x

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

U.S. Citizen

 

NUMBER
OF

SHARES

BENEFICIALLY

OWNED
BY

EACH

REPORTING

PERSON

WITH

 

5.

SOLE
VOTING POWER

0

6.

SHARED
VOTING POWER

 

2,242,091
shares

7.

SOLE
DISPOSITIVE POWER

0

8.

SHARED
DISPOSITIVE POWER

See
Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

See Row 6 above

10.

CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

¨

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

6.3%

 

 

12.

TYPE OF REPORTING PERSON

IN

Follow Aerie Pharmaceuticals Inc (NASDAQ:AERI)

Page 7 of 13